Rydel-Seiffer fork revisited: Beyond a simple case of black and white by Panosyan, FB et al.
From the Morton and Gloria Shulman Movement Disorders Clinic
and the Edmond J. Safra Program in Parkinson’s Disease, Division
of Neurology (A.F.), Division of Neurosurgery (F.S., M.L., A.M.L.),
Toronto Western Hospital–UHN, University of Toronto and Krem-
bil Research Institute (A.F., A.M.L), Toronto, Ontario, Canada.
Author contributions: Alfonso Fasano: drafting/revising the manu-
script, study concept or design, analysis or interpretation of data, accepts
responsibility for conduct of research and will give final approval,
acquisition of data, study supervision. Francesco Sammartino: draft-
ing/revising the manuscript, study concept or design, analysis or inter-
pretation of data, accepts responsibility for conduct of research and will
give final approval, acquisition of data, statistical analysis. Maheleth
Llinas: drafting/revising the manuscript, analysis or interpretation of
data, accepts responsibility for conduct of research and will give final
approval, statistical analysis, study supervision. Andres M. Lozano:
drafting/revising the manuscript, study concept or design, analysis or
interpretation of data, accepts responsibility for conduct of research and
will give final approval, contribution of vital reagents/tools/patients,
acquisition of data, statistical analysis, study supervision, obtaining
funding.
Study funding: No targeted funding reported.
Disclosure: A.M.L. is a consultant to the Focused Ultrasound
Foundation and has received research support from InSightec in
the past. Dr. Fasano has received grant support from the Univer-
sity of Toronto, the McLaughlin Centre, and the Michael J. Fox
Foundation; he received speaking honoraria from UCB Pharma,
Medtronic, Boston Scientific, AbbVie, Novartis, Chiesi Pharma-
ceutical, and TEVA; he is on an advisory board for AbbVie and
provided consultancies for UCB Pharma, Medtronic, Boston Sci-
entific, and AbbVie. Ms. Llinas and Dr. Sammartino report no
disclosures. Dr. Lozano holds stock ownership in medically related
fields (Functional Neuromodulation) and provided consultancies
for Medtronic St. Jude, Boston Scientific, and InSightec. Go to
Neurology.org for full disclosures.
Received January 8, 2016. Accepted in final form May 3, 2016.
Correspondence to Dr. Fasano: alfonso.fasano@uhn.ca
© 2016 American Academy of Neurology
1. Fasano A, Deuschl G. Therapeutic advances in tremor. Mov
Disord 2015;30:1557–1565.
2. Lipsman N, Schwartz ML, Huang Y, et al. MR-guided
focused ultrasound thalamotomy for essential tremor:
a proof-of-concept study. Lancet Neurol 2013;12:462–468.
3. Elias WJ, Huss D, Voss T, et al. A pilot study of focused
ultrasound thalamotomy for essential tremor. N Engl J Med
2013;369:640–648.
4. ChangWS, Jung HH, Kweon EJ, Zadicario E, Rachmilevitch I,
Chang JW. Unilateral magnetic resonance guided focused ultra-
sound thalamotomy for essential tremor: practices and clinicor-
adiological outcomes. J Neurol Neurosurg Psychiatry 2015;86:
257–264.
5. Sammartino F, Krishna V, Kon Kam King N, Lozano A,
Hodaie M. Tractography-based ventral intermediate
nucleus targeting: novel methodology and intraoperative
validation. Mov Disord Epub 2016 May 23.
6. Huss DS, Dallapiazza RF, Shah BB, Harrison MB,
Diamond J, Elias WJ. Functional assessment and quality
of life in essential tremor with bilateral or unilateral DBS
and focused ultrasound thalamotomy. Mov Disord 2015;
30:1937–1943.
7. Jung HH, Kim SJ, Roh D, et al. Bilateral thermal capsulot-
omy with MR-guided focused ultrasound for patients with
treatment-refractory obsessive-compulsive disorder: a proof-
of-concept study. Mol Psychiatry 2015;20:1205–1211.
RYDEL-SEIFFER FORK REVISITED: BEYOND
A SIMPLE CASE OF BLACK AND WHITE
In 1903, A. Rydel and F.W. Seiffer published the use of
what is now commonly known as the Rydel-Seiffer tun-
ing fork.1 In their paper, they described an adaptation of
the standard tuning fork to make it semiquantitative on
an 8-point scale in measuring vibration sensing. The
Rydel-Seiffer tuning fork has been used extensively over
the past century and normative values have been pub-
lished.2 It has also been validated with the use of more
modern sensory nerve action potentials.3 Vibration
threshold measurement with the Rydel-Seiffer tuning
fork is therefore increasingly used in outcomemeasures
assessing neuropathy from diverse etiologies:
chemotherapy-induced peripheral neuropathy,4
Charcot-Marie-Tooth disease,5 multifocal motor neu-
ropathy,6 and immune-mediated neuropathies.7
The modern Rydel-Seiffer tuning fork has a black
triangle on one prong and a white triangle on the sec-
ond prong (figure, A). After the fork is snapped into
motion, the prongs start to oscillate and the illusion of
2 triangles becomes visible on each damper. The inter-
sect between the 2 virtual triangles moves up the scale
with gradual attenuation of the amplitude of the
oscillation. The position of the intersect is recorded
on an arbitrary scale from 0 to 8 once the subject is
no longer perceiving vibration.
We have observed consistent discrepancy between
the values obtained from the black triangle in compari-
son to the white triangle on the Rydel-Seiffer fork. Val-
ues obtained from the virtual intersect of the white
triangle are consistently lower in comparison to that from
the black triangle (figure, C and D). This discrepancy
can be as much as 25% or 2 units in the scale of 0 to 8.
This is best appreciated during the motion of the prongs
(video on the Neurology® Web site at Neurology.org).
There is currently no report distinguishing between
the black and white scales and both are used inter-
changeably.2,3 Of note, the original publication from
Rydel and Seiffer depicts the tuning fork with 2 black
triangles on the dampers (figure, B). It is unclear as to
why or when a modification was made and one of the
black triangles was substituted with a white triangle.
Remarkably, the observed discrepancy between the 2
scales can be eliminated by simply darkening the white
triangle on the fork with a marker (figure, E and F). It is
of interest that, upon introducing color to the white
triangle (purple or red), the readings obtained from
the black triangle showed lower values in comparison
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to the colored triangle (video). The perceived intersec-
tion between the triangles seems to be therefore influ-
enced by the contrast and the color of the triangles. This
is likely attributable to visual afterimage processing,
although a more tangible explanation remains elusive.
To maintain an acceptable interrater reliability in
the use the Rydel-Seiffer tuning fork, we suggest that
the original design with the 2 black triangles is consid-
ered. Alternatively, consensus should be established
on which triangle to use in the future for clinical prac-
tice and clinical research.
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Figure Rydel-Seiffer tuning fork
(A) An example of a modern-day Rydel-Seiffer tuning fork. (B) Original design of the tuning fork as published by Rydel and
Seiffer in 1903 (reprinted with permission of Springer).1 (C) Rydel-Seiffer tuning fork at rest. (D) Rydel-Seiffer tuning fork in
motion with the black triangle showing intersect between 4 and 5 (on the 0 to 8 scale) and white triangle showing intersect
between 3 and 4 (discrepancy is better appreciated in the video). (E) Same Rydel-Seiffer tuning fork with the white triangle
blacked out at rest. (F) Rydel-Seiffer tuning forkwith 2 black triangles inmotion showing equivalent reading with intersect at 4.
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MACRA Changes How Neurologists Are Paid
What Is MACRA, and Why Is It Necessary?
The Medicare Access and CHIP Reauthorization Act of 2015—MACRA—replaced the
Medicare Sustainable Growth Rate formula for calculating physician payments. The rapidly rising
costs of health care in the US are unsustainable. Changes in the health care system are essential and
must happen now.
How Will MACRA Affect Physician Payment?
Our health care system is moving from “fee-for-service” payments to a wider array of “value-based”
payment models that put the patient at the center of care by calling for the improvement of the
quality, safety, and overall experience of patient care while demonstrating cost-effectiveness by
providing care that is less expensive and delivers similar or improved clinical outcomes.
Learn more at AAN.com/view/MACRA.
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